FILANA THERAPEUTICS, INC. - Common Stock (FLNA)
CUSIP: 14817C107
Q3 2019 13F Holders as of 30 Sep 2019
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 48,331,225
- Total 13F shares
- 1,823,694
- Share change
- -1,527,317
- Total reported value
- $2,188,000
- Price per share
- $1.20
- Number of holders
- 16
- Value change
- -$1,850,994
- Number of buys
- 8
- Number of sells
- 10
Quarterly Holders Quick Answers
What is CUSIP 14817C107?
CUSIP 14817C107 identifies FLNA - FILANA THERAPEUTICS, INC. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 14817C107:
Top shareholders of FLNA - FILANA THERAPEUTICS, INC. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| First Eagle Investment Management, LLC |
13F
|
Company |
3.5%
|
1,695,395
|
$2,051,000 | — | 30 Jun 2019 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
1.4%
|
682,792
|
$826,000 | — | 30 Jun 2019 | |
| Worth Venture Partners, LLC |
13F
|
Company |
0.61%
|
296,623
|
$359,000 | — | 30 Jun 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.39%
|
187,263
|
$226,000 | — | 30 Jun 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.35%
|
167,062
|
$202,000 | — | 30 Jun 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.15%
|
74,732
|
$90,000 | — | 30 Jun 2019 | |
| ENVESTNET ASSET MANAGEMENT INC |
13F
|
Company |
0.13%
|
62,892
|
$76,000 | — | 30 Jun 2019 | |
| PANAGORA ASSET MANAGEMENT INC |
13F
|
Company |
0.08%
|
37,697
|
$46,000 | — | 30 Jun 2019 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.05%
|
22,516
|
$28,000 | — | 30 Jun 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.05%
|
22,105
|
$27,000 | — | 30 Jun 2019 | |
| Virtu Financial LLC |
13F
|
Company |
0.04%
|
20,707
|
$25,000 | — | 30 Jun 2019 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
19,220
|
$23,000 | — | 30 Jun 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.04%
|
18,684
|
$23,000 | — | 30 Jun 2019 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.03%
|
14,285
|
$17,000 | — | 30 Jun 2019 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.03%
|
13,743
|
$17,000 | — | 30 Jun 2019 | |
| CWM, LLC |
13F
|
Company |
0%
|
200
|
$17,000 | — | 30 Jun 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
7,137
|
$9,000 | — | 30 Jun 2019 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
3,756
|
$5,000 | — | 30 Jun 2019 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
2,232
|
$3,000 | — | 30 Jun 2019 | |
| LADENBURG THALMANN FINANCIAL SERVICES INC. |
13F
|
Company |
0%
|
2,200
|
$3,000 | — | 30 Jun 2019 | |
| FMR LLC |
13F
|
Company |
0%
|
1,000
|
$1,000 | — | 30 Jun 2019 |
Institutional Holders of FILANA THERAPEUTICS, INC. - Common Stock (FLNA) as of Q3 2019
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2019 vs Q2 2019 Across Filers
| Investor | Q2 2019 Shares | Q3 2019 Shares | Share Diff | Share Chg % | Q2 2019 Value $ | Q3 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
An asterisk sign (*) next to the price indicates that the price is likely invalid.